Toxic effects of aflatoxin B1 on embryonic development of zebrafish (Danio rerio): Potential activity of piceatannol encapsulated chitosan/poly (Lactic Acid) nanoparticles

Anti-Cancer Agents in Medicinal Chemistry

Volumn 15, Issue 2, 2015, Pages 248-257

  Dhanapal, Jeevitha ^a   Ravindrran, Malathy Balaraman ^a   Baskar, Santhosh K ^b  

^a SATHYABAMA UNIVERSITY   (India)

^b CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

AflatoxinB1; Chitosan; Piceatannol; Poly lactic acid; Toxicity; Zebrafish

Indexed keywords

AFLATOXIN B1; ANTHRAQUINONE; CHITOSAN NANOPARTICLE; CHITOSAN POLYLACTIC ACID NANOPARTICLE; PICEATANNOL; PICEATANNOL ENCAPSULATED CHITOSAN NANOPARTICLE; POLYLACTIC ACID; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; 3,3',4,5'-TETRAHYDROXYSTILBENE; CHITOSAN; DRUG CARRIER; LACTIC ACID; NANOPARTICLE; POLYMER; STILBENE DERIVATIVE;

ARTICLE; CHEMICAL INTERACTION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DRUG EXPOSURE; DRUG STABILITY; EMBRYO DEVELOPMENT; HATCHING; HEART RATE; IN VIVO STUDY; INFRARED SPECTROSCOPY; MORTALITY; NANOENCAPSULATION; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SURVIVAL; ZEBRA FISH; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING;

AFLATOXIN B1; ANIMALS; CHITOSAN; DRUG CARRIERS; EMBRYONIC DEVELOPMENT; HEART RATE; LACTIC ACID; NANOPARTICLES; PARTICLE SIZE; POLYMERS; STILBENES; ZEBRAFISH;

EID: 84926210240     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/1871520614666141016165057     Document Type: Article

References (76)

1. Bennett, J.W.; Klich, M. Mycotoxins. Clin. Microbiol. Rev., 2003, 16, 497-516
2. EFSA. Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to the potential increase of consumer health risk by a possible increase of the existing maximum levels for Aflatoxins in almonds, hazelnuts and pistachios and derived products. EFSA J., 2007, 446, 1-127
3. Shuaib, F.M.; Jolly, P.E.; Ehiri, J.E.; Yatich, N.; Jiang, Y.; Funkhouser, E.; Person, S.D.; Wilson, C.; Ellis, W.O.; Wang, J.S.; Williams, J.H. Association between birth outcomes and aflatoxin B1 biomarker blood levels in pregnant women in Kumasi, Ghana. Trop. Med. Int. Health, 2010,15,160-167
4. Reddy, K.R.N.; Farhana, N.I.; Salleh, B. Occurrence of Aspergillus spp and aflatoxin B1 in Malaysian foods used for human consumption. J. Food Sci., 2011, 76, 99-104
5. IARC, International agency for research on cancer (IARC): monographs on the evaluation of carcinogenicity risk to humans: Some naturally occurring substances. In: Food items and constituents heterocyclic aromatic amines and mycotoxins. Lyon, France, 1993, 56, 245-395
6. Smela, M.E.; Hamm, M.L.; Henderson, P.T.; Harris, C.M.; Harris, T.M.; Essigmann JM. The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. Proc. Natl. Acad. Sci., 2002, 99, 6655-6660
7. Bedard, L.L.; Massey, T.E. Aflatoxin B1-induced DNA damage and its repair. Cancer Lett., 2006, 241, 174-183
8. IARC. IARC monographs on the evaluation of carcinogenic risks to humans a review of human carcinogens: Chemical Agents and Related Occupations. 100F; 2012
9. Coulombe, Jr, R.A.; Sharma, R.P. Clearance and excretion of intratracheally and orally administered aflatoxin B1 in the rat. Food Chem. Toxicol., 1985, 23, 827-830
10. Cupid, B.C.; Lightfoot, T.J.; Russell, D.; Gant, S.; Turner, P.C.; Dingley, K.H.; Curtis, K.D.; Leveson, S.H.; Turteltaub, K.W.; Garner, R.C. The formation of AFB1-macromolecular adducts in rats and humans at dietary levels of exposure. Food Chem. Toxicol., 2004, 42, 559-569
11. Firmin, S.; Gandia, P.; Morgavi, D.P.; Houin, G.; Jouany, J.P.; Bertin, G.; Boudra, H. Modification of aflatoxin B1 and ochratoxin a toxicokinetics in rats administered a yeast cell wall preparation. Food Addit. Contam., 2010, 27,1153-1160
12. Jubert, C.; Mata, J.; Bench, G.; Dashwood, R.; Pereira, C.; Tracewell, W.; Turteltaub, K.; Williams, D.; Bailey, G. Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B (1) pharmacokinetics in human volunteers. Cancer Prev. Res., 2009, 2, 1015-1022
13. Wong, Z.A.; Hsieh, D.P.H. The comparative metabolism and toxicokinetics of aflatoxin B1 in the monkey, rat and mouse. Toxicol. Appl. Pharmacol., 1980, 55,115-125
14. Halver, J.E. Aflatoxicosis and trout hepatoma. In: Aflatoxin: Scientific background, control and implications. Ed. LA. Goldblatt. Academic Press, New York 1969, 265-306
15. Sato, S.; Matsushima, T.; Tanaka, N.; Sugimura, T.; Takashima, F. Hepatic tumours in the guppy (Lebistes reticulatus) induced by aflatoxin B1 dimethylnitrosamine and 2-acetyl aminofluorene. J. Nat. Cancer Inst., 1973, 50,765-778
16. Jantrarotai, W.; Lovell, R.T.; Grizzle, J.M. Acute toxicity of aflatoxin B1 to channel catfish. J. Aquat. Animal Health, 1990, 2, 237-247
17. Chavez, S.M.C.; Martinez, P.C.A.; Osorio, M.I. Pathological effects of feeding young Oreochromis niloticus diets supplemented with different levels of aflatoxin B1. Aquaculture, 1994, 127, 49-61
18. Towner, R.A.; Oian, S.Y.; Kadiiska, M.B.; Mason, R.P. In vivo identification of aflatoxin-induced free radicals in rat bile. Free Rad. Biol. Med., 2003, 35,1330-1340
19. Madhusudhanan, N.; Kavithalakshmi, S.N.; Shanmugasundaram, E.R.B.; Shanmugasundaram, K.R. Aflatoxin B1-induced DNA damage in labeo rohita: Protective effect of an antioxidant supplement, Amrita Bindu. Basic Clin. Pharmacol. Toxicol., 2006, 98,473-479
20. Ingham, J.L. 3,5,4’-Trihydroxystilbene as a phytoalexin from groundnuts (Arachis hypogaea). Phytochemistry, 1976, 15, 1791-1793
21. Langcake, P.; Pryce, R.J. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol. Plant Pathol., 1976, 9, 77-86
22. Sobolev, V.S.; Cole, R.J.; Dorner, J.W. Isolation, purification, and liquid chromatographic determination of stilbene phytoalexins in peanuts. J. AOAC Int., 1995, 78, 1177-1182
23. Bavaresco, L.; Vezzulli, S.; Battilani, P.; Giorni, P.; Pietri, A.; Bertuzzi, T. Effect of ochratoxin A-producing Aspergilli on stilbenic phytoalexin synthesis in grapes. J. Agric. Food Chem., 2003, 51, 6151-6157
24. Cantos, E.; Espin, J.C.; Fernandez, M.J.; Oliva. J.; Tomas, B.F.A. Postharvest UV-C-irradiated grapes as a potential source for producing stilbene-rich red wines. J. Agric. Food Chem., 2003, 51, 1208-1214
25. Cantos, E.; Espin, J.C.; Tomas BFA. Postharvest stilbeneenrichment of red and white table grape varieties using UV-C irradiation pulses. J. Agric. Food Chem., 2002, 50, 6322-6329
26. Arora, M.K.; Strange, R.N. Phytoalexin accumulation in groundnuts in response to wounding. Plant Sci., 1991, 78,157-163
27. Ferrigni, N.R.; McLaughlin, J.L.; Powell, R.G.; Smith, C.R. Use of potato disc and brine shrimp bioassays to detect activity and isolation of piceatannol as the antileukemic principle from the seeds of Euphorbia lagascae. J. Nat. Prod., 1984, 47, 347-352
28. Kita, Y.; Miura, Y.; Yagasaki, K. Antiproliferative and anti-invasive effect of piceatannol, a polyphenol present in grapes and wine, against hepatoma AH109A cells. J. Biomed. Biotechnol., 2012, 1-7
29. Wieder, T.; Prokop, A.; Bagci, B.; Essmann, F.; Bernicke, D.; Schulze- Osthoff, K.; Dörken, B.; Schmalz, H.G.; Daniel, P.T.; Henze, G. Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts. Leukemia, 2001, 15, 1742-1753
30. Son, P.S.; Park, S.A.; Na, H.K.; Jue, D.M.; Kim, S.; Surh, Y.J. Piceatannol, a catechol-type polyphenol, inhibits phorbol esterinduced NF-κB activation and cyclooxygenase-2 expression in human breast epithelial cells: Cysteine 179 of IKKβ as a potential target. Carcinogenesis, 2010, 31,1442-1449
31. Kwon, J.Y.; Seo, S.G.; Heo, Y.S.; Yue, S.; Cheng, J.X.; Lee, K.W.; Kim, K.H. Piceatannol, natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in early phase of differentiation. J. Biol. Chem., 2012, 287, 11566-11578
32. Murias, M.; Jager, W.; Handler, N.; Erker, T.; Horvath, Z.; Szekeres, T.; Nohl, H.; Gille, L. Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: Structureactivity relationship. Biochem. Pharmacol., 2005, 69, 903-912
33. Ovesna, Z.; Kozics, K.; Bader, Y.; Saiko, P.; Handler, N.; Erker, T.; Szekeres, T. Antioxidant activity of resveratrol, piceatannol and 3,3',4,4',5,5'-hexahydroxy-trans-stilbene in three leukemia cell lines. Oncol. Rep., 2006, 16, 617-624
34. Piotrowska, H.; Kucinska, M.; Murias, M. Biological activity of piceatannol leaving the shadow of resveratrol. Mutat. Res., 2012, 750, 60-82
35. Roupe, K.A.; Yanez, J.A.; Teng, X.W.; Davies, N.M. Pharmacokinetics of selected stilbenes: Rhapontigenin, piceatannol and pinosylvin in rats. J. Pharm. Pharmacol., 2006, 58, 1443-1450
36. Geng, L.; Yonglong, Z.; Qing, M.; Mozhen, W.; Yuee, F. Preparation characterization and aggregation behavior of amphiphilic chitosan derivative having poly (l-lactic acid) side chains. Carbohyd. Polym., 2008, 72,60-66
37. Li, X.Y.; Kong, X.Y.; Shi, S.; Zheng, X.L.; Guo, G.; Wei, Y.Q.; Qian, Z.Y. Preparation of alginate coated chitosan microparticles for vaccine delivery. BMC Biotechnol., 2008, 8,89-99
38. Anitha, A.; Deepa, N.; Chennazhi, K.P.; Nair, S.V.; Tamura, H.; Jayakumar, R. Development of mucoadhesive thiolated chitosan nanoparticles for biomedical applications. Carbohyd. Polym., 2011, 83, 66-73
39. Jayakumar, R.; Chennazhi, K.P.; Muzzarelli, R.A.A.; Tamura, H.; Nair, S.V.; Selvamurugan, N. Chitosan conjugated DNA nanoparticles in gene therapy. Carbohyd. Polym., 2010,79,1-8
40. Chen, M.C.; Yeh, G.H.C.; Chiang, B.H. Antimicrobial and physicochemical properties of methylcellulose and chitosan films containing a preservative. J. Food Process. Preserv., 1996, 20,379-390
41. Li, X.Y.; Li, X.; Kong, X.Y.; Shi, S.; Guo, G.; Zhang, J.; Luo, F.; Zhao, X.; Wei, Y.Q.; Qian, Z.Y.; Yang, L. Preparation of Ntrimethyl chitosan-protein nanoparticles intended for vaccine delivery. J. Nanosci. Nanotechnol., 2010, 10, 4850-4858
42. Khor, E. Chitin: Fulfilling a biomaterials promise. Oxford, UK: Elsevier Science 2001
43. Kweon, D.K.; Kang, D.W. Drug release behavior of chitosan-gpoly (vinyl alcohol) copolymer matrix. J. Appl. Polym. Sci., 1999, 74, 458-464
44. Jayakumar, R.; Reis, R.L.; Mano, J.F. Synthesis and characterization of pH-sensitive thiol-containing chitosan beads for controlled drug delivery applications. J. Bioact. Compat. Polym., 2006, 21,327-340
45. Anitha, A.; Divya, R.V.V.; Krishna, R.; Sreeja, V.; Selvamurugan, N. Synthesis, characterization, cytotoxicity and antibacterial studies of chitosan, O-carboxymethyl and N, O-carboxymethyl chitosan nanoparticles. Carbohyd. Polym., 2009, 78,672-677
46. Rouzes, C.; Leonard, M.; Durand, A.; Dellacherie, E. Influence of polymeric surfactants on the properties of drug-loaded PLA nanospheres. Colloids Surf B: Biointerf., 2003, 32,125-135
47. Xiong, X.Y.; Tam, K.C.; Gan, L.H. Release kinetics of hydrophobic and hydrophylic model drugs from pluronic F127/poly (lactid acid) nanoparticles. J. Contr. Rel., 2005, 103,73-82
48. Rahul, M.R.; Amol, V.J.; Douglas, E.H. Poly lactic acid modifications. Prog. Polym. Sci., 2010, 35,338-356
49. Nagarwal, R.C.; Singh, P.N.; Kant, S.; Maiti, P.; Pandit, J.K. Chitosan coated PLA nanoparticles for ophthalmic delivery: Characterization, in-vitro and in-vivo study in rabbit eye. J. Biomed. Nanotech., 2010, 6, 648-657
50. Ashish, D.; Binulal, N.S.; Anitha, A.; Nair, S.V.; Furuike, T.; Tamura, H.; Jayakumar, R. Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications. Carbohyd. Polym., 2010, 80, 833-838
51. Sifeng, W.; Kechun, L.; Ximing, W.; Qiuxia, H.; Xiqiang, C. Toxic effects of celastrol on embryonic development of zebrafish (Danio rerio). Drug Chem. Toxicol., 2010, 34, 61-65
52. Parng, C. In vivo zebrafish assays for toxicity testing. Curr. Opin. Drug Discov. Dev., 2005, 8,100-106
53. Rubinstein, A.L. Zebrafish: From disease modeling to drug discovery. Curr. Opin. Drug Dev., 2003,6,218-222
54. Lohr, J.L.; Yost, H.J. Vertebrate model system in the study of early heart development: Xenopus and zebrafish. Am. J. Med. Genet., 2000, 97, 248-257
55. Weigt, S.; Huebler, N.; Strecker, R.; Braunbeck, T.; Broschard, T.H. Zebrafish (Danio rerio) embryos as a model for testing proteratogens. Toxicol., 2011, 281, 25-36
56. Jeevitha, D.; Kanchana, A. Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: Synthesis, characterization and in vitro cytotoxicity evaluation. Coll. Surf. B Biointer., 2013, 101, 126-134
57. Whitlock, K.E.; Westerfield, M. The olfactory placodes of the zebrafish form by convergence of cellular fields at the edge of the neural plate. Development, 2000, 127, 3645-3653
58. Jia, X.; Jinhui, Z.; Weiquan, G.; Hongwei, L.; Hongyan, W.; Junfeng, L. Preparation of chitosan/PLA blend micro/nanofibers by electrospinning. Mat. Lett., 2009, 63, 658-660
59. Zahr, A. S.; Davis, C. A.; Pishko, M.V. Macrophage uptake of core–shell nanoparticles surface modified with poly(ethylene glycol). Langmuir, 2006, 22, 8178-8185
60. Rajan, M.; Raj, V. Encapsulation characterisation and in-vitro release of anti-tuberculosis drug using chitosan–poly ethylene glycol nanoparticles. Int. J. Pharm. Pharmaceut. Sci., 2012, 4, 255-259
61. De Vries, H.R., Maxwell, S.M.; Hendrickse, R.G. Foetal and neonatal exposure to aflatoxins. Acta Paediatr. Scand., 1989, 78,373-378
62. Wangikar, P.B.; Dwivedi, P.; Sharma, A.K.; Sinha, N. Effect in rats of simultaneous prenatal exposure to ochratoxin A and aflatoxin B1. II. Histopathological features of teratological anomalies induced in fetuses. Birth Defects Res. B. Dev. Reprod. Toxicol., 2004, 71, 352-358
63. Wangikar, P.B.; Dwivedi, P.; Sinha, N.; Sharma, A.; Telang, A.G. Teratogenic effects in rabbits of simultaneous exposure to ochratoxin A and aflatoxin B1 with special reference to microscopic effects. Toxicol., 2005, 215,37-47
64. McGrath, P.; Li, C.Q. Zebrafish: A predictive model for assessing drug-induced toxicity. Drug Discov. Today, 2008, 13, 394-401
65. Arnaout, R.; Ferrer, T.; Huisken, J.; Spitzer, K.; Stainier, D.Y.; Tristani-Firouzi, M.; Neil, C.C. Zebrafish model for human long QT syndrome. Proc. Nat. Acad. Sci., 2007, 104, 11316-11321
66. Milan, D.J.; Jones, I.L.; Ellinor, P.T.; MacRae, C.A. In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. Am. J. Physiol. Heart Circ. Physiol., 2006, 291, H269-273
67. Yang, L.; Ho, N.Y.; Alshut, R.; Legradi, J.; Weiss, C.; Reischl, M.; Mikut, R.; Liebel, U.; Müller, F.; Strähle, U. Zebrafish embryos as models for embryotoxic and teratological effects of chemicals. Reprod. Toxicol., 2009, 28, 245-253
68. Yu, P.B.; Hong, C.C.; Sachidanandan, C.; Babitt, J.L.; Deng, D.Y.; Hoyng, S.A.; Lin, H.Y.; Bloch, K.D.; Peterson, R.T. Dorsomorphin inhibits BMPsignals required for embryogenesis and iron metabolism. Nat. Chem. Biol., 2008, 4, 33-41
69. Stern, H.M.; Murphey, R.D.; Shepard, J.L.; Amatruda, J.F.; Straub, C.T.; Pfaff, K.L.; Weber, G.; Tallarico, J.A.; King, R.W.; Zon, L.I. Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat. Chem. Biol., 2005, 1,366-370
70. Yeh, J.R.; Munson, K.M.; Elagib, K.E.; Goldfarb, A.N.; Sweetser, D.A.; Peterson, R.T. Discovering chemical modifiers of oncogeneregulated hematopoietic differentiation. Nat. Chem. Biol., 2009, 5, 236-243
71. Mathew, L.K.; Sengupta, S.; Kawakami, A.; Andreasen, E.A.; Lohr, C.V.; Loynes, C.A.; Renshaw, S.A.; Peterson, R.T.; Tanguay, R.L. Unraveling tissue regeneration pathways using chemical genetics. J. Biol. Chem., 2007, 282, 35202-35210
72. North, T.E.; Goessling, W.; Walkley, C.R.; Lengerke, C.; Kopani, K.R.; Lord, A.M.; Weber, G.J.; Bowman, T.V.; Jang, I.H.; Grosser, T.; Fitzgerald, G.A.; Daley, G.Q.; Orkin, S.H.; Zon, L.I. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature, 2007, 447,1007-1011
73. Tran, T.C.; Sneed, B.; Haider, J.; Blavo, D.; White, A.; Aiyejorun, T.; Baranowski, T.C.; Rubinstein, A.L.; Doan, T.N.; Dingledine, R.; Sandberg, E.M. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Cancer Res., 2007, 67, 11386-11392
74. Molina, G.A.; Watkins, S.C.; Tsang, M. Generation of FGF reporter transgenic zebrafish and their utility in chemical screens. BMC Dev. Biol., 2007, 7, 62
75. Peterson, R.T.; Shaw, S.Y, Peterson, T.A, Milan, D.J, Zhong, T.P.; Schreiber, S.L.; MacRae, C.A, Fishman, M.C. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat. Biotechnol., 2004, 22,595-599
76. Sachidanandan, C.; Yeh, J.R.; Peterson, Q.P.; Peterson, R.T. Identification of a novel retinoid by small molecule screening with zebrafish embryos. PLOS One, 2008, 3(4), e1947.